Skip to main content
. 2019 Nov 14;17(1):1479164119883540. doi: 10.1177/1479164119883540

Table 1.

Age, gender, disease duration, smoking habit and clinical characteristics of subjects divided according to suggested therapy.

Empagliflozin group Incretin group
Number 20 15
Age (years) 58 ± 9 60 ± 7
Males (%) 75 80
Disease duration (years) 15 ± 9 17 ± 10
Obesity (%) 50 40
Hypertension (%) 93 100
Hyperlipidaemia (%) 90 93
Smoking habit (%) 30 33

SD: standard deviation.

The data are expressed as the means ± SDs or percentages.